Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01151Indinavir sulfate--
BADD_D01154Indium in-111 pentetreotide--
BADD_D01156Indomethacin--
BADD_D01159Insulin (human)--
BADD_D01160Insulin aspart--
BADD_D01162Insulin detemir--
BADD_D01165Insulin lispro--
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01168Interferon alfacon-1--
BADD_D01169Interferon beta-1a--
BADD_D01170Interferon beta-1b--
BADD_D01178Iodixanol--
BADD_D01180Iohexol--
BADD_D01181Iopamidol--
BADD_D01182Iopromide--
BADD_D01189Ioxilan--
BADD_D01191Ipratropium--
BADD_D01194Irbesartan0.001652%
BADD_D01195Irinotecan--
BADD_D01196Irinotecan hydrochloride--
BADD_D01197Iron0.003717%
BADD_D01198Iron dextran--
BADD_D01199Iron sucrose--
BADD_D01204Isoniazid0.026964%
BADD_D01205Isoprenaline--
BADD_D01207Isoproterenol hydrochloride--
BADD_D01209Isosorbide--
BADD_D01210Isosorbide dinitrate0.000411%
BADD_D01211Isosorbide mononitrate--
The 21th Page    First    Pre   21 22 23 24 25    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target